CanSinoBIO

CanSinoBIO ConSino Bio specializes in the development and production of high-qua

With a registered capital of RMB 156 million, ConSinoBio is a national high-tech enterprise founded by the senior management team of a multinational pharmaceutical company. With the mission of providing solutions for the prevention of infectious diseases and infectious diseases worldwide, ConSino Bio specializes in the development and production of high-quality human vaccines.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

-

Founded

Jan 13, 2009

HQ location

Tianjin, China

Legal name

Tianjin Cansino Biotechnology Inc

Employees

301-500

See more